Dr. Rosa M. Navarro, MD

Dr. Navarro practices at Navarro Pain Control Group Inc. in Chula Vista, California.

Dr. Navarro's NPI, 1083691802, was assigned on December 22, 2005. Dr. Navarro graduated from University of Illinois College of Medicine - Chicago in 1994. Dr. Navarro holds California license C53858.

Dr. Navarro's primary practice is Navarro Pain Control Group Inc., at 2452 Fenton St, Chula Vista, CA 91914 in San Diego County. The practice phone is (619) 600-5309.

Dr. Navarro's primary practice is Navarro Pain Control Group Inc. in Chula Vista, California. The medical group on file is Navarro Pain Control Group, Inc. Dmand AI also links Dr. Navarro to 2 more home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Navarro practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Navarro's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Navarro is board certified in pain medicine by the American Board of Anesthesiology. Dmand AI has Dr. Navarro's licenses on file in 4 states: California, Indiana, District of Columbia and Illinois.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Navarro treats.

CMS data shows 4,819 Medicare services from Dr. Navarro across 22 procedure codes in 2024, for 235 Medicare patients. Medicare paid $144,599 for them. Every service was in an office.

CMS counts 235 Medicare patients who saw Dr. Navarro in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have arthritis, and 74% have high blood pressure. 55% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Navarro's median patient age at 66, with 72% women.

In 2024, Dr. Navarro wrote 508 Medicare Part D claims for 196 patients. 96% of them were for generic drugs. CMS names the drug for 430 of them, across 8 drugs with 11 or more claims each, at $5,589 in total drug cost. In 2023, CMS named 458 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Navarro for performance year 2024, reported individually. Dr. Navarro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Navarro as offering telehealth.

Dmand AI links 3 papers to Dr. Navarro in 2012. Dr. Navarro has published most often in Neuromodulation. Dr. Navarro's most frequent co-authors are Magdalena Anitescu, MD, Tammy Lynn Dann, DO and Jessica Berryman Jameson, MD.

Dmand AI links Dr. Navarro to 1 clinical trial. Conditions studied include Spinal Stenosis and Spinal Diseases.

CMS Open Payments shows 429 general payments to Dr. Navarro from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Medtronic USA, Inc. paid the most, $34,193.

Dr. Navarro graduated from University of Illinois College of Medicine - Chicago in 1994.

Dr. Navarro is in network with 15 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.